Every Form 4 that Regency Ctrs Corp (REG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow REG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full REG filings page.
LINNEMAN PETER reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director Peter Linneman received an award of 318 shares of Common Stock on August 7, 2026, representing director's fees paid in stock under the company's Omnibus Incentive Plan. After this stock-settled fee, he directly owns 56,061 shares of Regency Centers.
Klein Karin reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director Karin Klein received a grant of 382 shares of common stock on August 7, 2026, as director’s fees paid in stock under Regency’s Omnibus Incentive Plan. Following this stock-based fee payment, Klein directly holds 25,790 shares of Regency Centers common stock.
Parrell Mark J. reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director Mark J. Parrell received a 334-share grant of common stock on August 7, 2026 as director's fees paid in stock under Regency's Omnibus Incentive Plan. Following this equity award, he directly holds 686 shares of Regency Centers common stock.
BLANKENSHIP C RONALD reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director C. Ronald Blankenship received a grant of 167 shares of Common Stock on August 7, 2026, as director's fees paid in stock under Regency's Omnibus Incentive Plan. After this stock-based fee award, he directly holds 114,923 shares of Regency Centers common stock.
REGENCY CENTERS CORP Principal Accounting Officer Terah L. Devereaux reported two common stock transactions. On June 12, 2026, Devereaux made an open-market sale of 1,240 shares of common stock at $80.135 per share and also disposed of 620 shares as a bona fide gift for no consideration.
Regency Centers Corp director Bryce Blair reported stock-based compensation activity involving the vesting of previously granted awards. On May 11, 2026, restricted stock units and related dividend equivalent rights vested under Regency’s Omnibus Incentive Plan and were settled in shares of common stock.
The filing shows 1,736 shares of restricted stock converting into common stock, along with 71 dividend equivalent rights that also converted into common shares on a one-for-one basis. These are non-cash, compensation-related exercises rather than open-market purchases or sales, and reflect routine equity award vesting for a board member.
REGENCY CENTERS CORP director Peter Linneman increased his holdings through equity compensation. On May 11, 2026, he acquired a total of 1,807 shares of common stock via the vesting of restricted stock and settlement of related dividend equivalent rights under Regency's Omnibus Incentive Plan.
These transactions were recorded as exercises or conversions of derivative securities rather than open-market purchases or sales. Following the transactions, Linneman directly holds 55,743 shares of Regency common stock.
Regency Centers director C. Ronald Blankenship reported routine equity compensation vesting. On May 11, 2026, he acquired 1,952 shares of Regency Centers common stock through the vesting and settlement of restricted stock and related dividend equivalent rights under the company’s Omnibus Incentive Plan. These transactions reflect compensation-related exercises, not open‑market purchases or sales, and left him holding 114,679 common shares directly.
Regency Centers Corp director Karin Klein acquired additional common stock through equity compensation vesting. On 2026-05-11, 1,807 shares of common stock were delivered upon the exercise or conversion of previously granted awards, rather than through open-market purchases.
The transactions reflect vesting of 1,736 shares of restricted stock under Regency's Omnibus Incentive Plan and settlement of 71 dividend equivalent rights, each equivalent to one common share. After these transactions, Klein directly holds 25,408 shares of Regency Centers common stock.
Regency Centers Corp director Deirdre Evens reported routine equity compensation activity. On May 11, 2026, she exercised derivative awards tied to restricted stock and dividend equivalent rights, converting a total of 1,807 units into common stock at a stated price of $0.00 per share.
Footnotes explain that 1,736 units reflect vesting of a restricted stock grant under Regency's Omnibus Incentive Plan, while 71 units are dividend equivalent rights that accrued as dividends were paid and settled in common shares when the related restricted stock vested. No open-market buys or sales were reported.
Regency Centers Corp director Thomas W. Furphy reported compensation-related equity activity, not open-market trading. On 2026-05-11, he exercised and settled equity awards covering a total of 1,807 shares of Regency common stock through the vesting of restricted stock and related dividend equivalent rights. The footnotes explain that these awards vested under Regency’s Omnibus Incentive Plan, with dividend equivalents converting into common shares as company dividends were paid. The filing shows only derivative exercises and award vesting, with no reported share sales or cash purchases.
Regency Centers Corp director Kristin Ann Campbell increased her direct holdings through equity compensation vesting. On May 11, 2026, she acquired a total of 1,807 shares of common stock via the vesting of restricted stock and settlement of dividend equivalent rights. Following these transactions, she directly owns 6,797 shares of Regency Centers common stock. The footnotes explain that the 1,736 restricted shares vested under Regency’s Omnibus Incentive Plan and 71 dividend equivalents, each equal to one common share, were settled in stock as the related restricted stock vested.
Regency Centers Corp director Gary E. Anderson reported acquiring common stock through equity award vesting. On May 11, 2026, he received 1,807 shares of common stock by exercising or converting previously granted awards.
The filing shows 1,736 shares issued from vesting of restricted stock and 71 shares issued from settlement of dividend equivalent rights. Footnotes explain these arose under Regency’s Omnibus Incentive Plan as compensation, not open-market purchases or sales, and related dividend rights were settled into common stock.
REGENCY CENTERS CORP director James H. Simmons III acquired additional common stock through equity award vesting rather than open-market trading. On May 11, 2026, he exercised and settled equity grants covering 1,807 shares of common stock, consisting of 1,736 restricted stock and 71 dividend equivalent rights under Regency’s Omnibus Incentive Plan. Following these compensation-related transactions, the filing shows he directly owns 8,049 shares of common stock.
BLANKENSHIP C RONALD reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director C. Ronald Blankenship received 453 shares of Common Stock as compensation. The shares were granted as director's fees paid in stock under Regency's Omnibus Incentive Plan rather than through an open-market purchase. Following this award, Blankenship directly holds 112,804 shares of Regency Centers Common Stock.
Parrell Mark J. reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director Mark J. Parrell increased his equity stake through compensation awards. He received 352 shares of common stock as director’s fees paid in stock under Regency’s Omnibus Incentive Plan and 2,150 shares via a restricted stock grant that vests 100% on May 6, 2027.
Regency Centers Corp director Peter Linneman reported stock-based compensation and a restricted stock conversion. On May 6, 2026, he received 336 shares of common stock as director’s fees paid in stock under Regency’s Omnibus Incentive Plan. The filing also shows the exercise of a Restricted Stock Grant covering 2,150 shares of common stock. These shares vest 100% on May 6, 2027. Following these acquisitions, Linneman directly owns 53,936 shares of Regency Centers common stock, reflecting a routine increase in his equity stake through compensation awards.
Regency Centers Corp director Karin Klein reported equity-based compensation on May 6, 2026. She received 403 shares of Common Stock as director’s fees paid in stock under Regency’s Omnibus Incentive Plan, bringing her directly held Common Stock to 23,601 shares.
She also acquired a Restricted Stock Grant covering 2,150 shares of Common Stock through a derivative transaction. According to the disclosure, these restricted shares vest 100% on May 6, 2027, reflecting a time-based compensation award rather than an open-market trade.
REGENCY CENTERS CORP director James H. Simmons III exercised a restricted stock grant for 2,150 shares of common stock. The filing classifies this as a derivative exercise/conversion with no cash price per share, indicating a compensation-related equity award rather than an open‑market trade. Following the transaction, Simmons holds 2,150 shares from this grant directly. According to the footnote, these shares vest 100% on May 6, 2027, meaning they become fully earned on that date if conditions are satisfied.
Regency Centers Corp director Thomas W. Furphy reported a compensation-related equity transaction. He exercised a derivative security labeled as a Restricted Stock Grant to acquire 2,150 shares of Common Stock at a price of $0.00 per share, held directly.
After this transaction, his reported direct holdings of this security total 2,150 shares. A footnote states that these shares vest 100% on May 6, 2027, indicating they are subject to a time-based vesting schedule rather than an open-market purchase or sale.
Regency Centers Corp director Deirdre Evens reported a compensation-related stock transaction. She exercised a derivative tied to a Restricted Stock Grant to acquire 2,340 shares of Common Stock at a price of $0.00 per share. Following this transaction, she directly holds 2,340 shares. According to a footnote, these shares vest 100% on May 6, 2027, indicating they are subject to a time-based vesting schedule rather than an open-market purchase or sale.
Regency Centers Corp director Kristin Ann Campbell reported a compensation-related stock transaction. She exercised a derivative tied to a restricted stock grant to acquire 2,150 shares of common stock, leaving her with 2,150 shares held directly after the transaction. According to the footnote, these shares vest 100% on May 6, 2027, indicating this is a time-based equity award rather than an open-market purchase or sale.
Regency Centers Corp director Gary E. Anderson received equity compensation in the form of restricted stock. On May 6, 2026, he acquired 2,150 shares of common stock through a restricted stock grant recorded as a derivative exercise at a price of $0.00 per share.
The award vests 100% on May 6, 2027, meaning Anderson must remain eligible through that date before the shares fully vest. After this grant, his reported direct holdings from this award total 2,150 shares, reflecting a routine, compensation-related transaction rather than an open‑market purchase or sale.
REGENCY CENTERS CORP director Bryce Blair reported an acquisition of equity through compensation. On May 6, 2026, he exercised a derivative award labeled as a Restricted Stock Grant to acquire 2,150 shares of underlying Common Stock at a price of $0.00 per share.
Following the transaction, Blair directly holds 2,150 shares related to this award. According to the footnote, these shares vest 100% on May 6, 2027, indicating this is a time-based equity grant rather than an open-market purchase or sale.
Regency Centers Corp executive Nicholas Andrew Wibbenmeyer, Western Regional President & CIO, sold 7,927 shares of common stock in an open-market transaction. The sale occurred on May 5, 2026 at a weighted average price of $79.0608 per share.
The shares were sold in multiple trades at prices ranging from $78.95 to $79.15. After this transaction, Wibbenmeyer directly holds 33,068.55 shares of Regency Centers common stock, indicating he continues to maintain a substantial equity position in the company.
REGENCY CENTERS CORP Executive Chairman Martin E. Stein Jr., through affiliated entities, reported open-market sales of 274,615 shares of common stock on May 4, 2026 at weighted average prices in the $78 range. The transactions were executed by The Regency Group, Inc., Regency Group II and related trusts, with prices based on multiple trades within disclosed ranges around $78 per share. After these sales, Stein continues to hold 316,680 shares directly and 4,000 shares indirectly through a trust.
REGENCY CENTERS CORP Executive Chairman Martin E. Stein Jr. reported charitable-style transfers of company stock held indirectly through a trust. A Grantor Retained Annuity Trust established for his daughters made bona fide gifts of 8,066, 8,067 and 8,068 shares of Common Stock, totaling 24,201 shares, at no consideration. After the most recent 8,068-share gift on May 14, 2024, the trust’s reported Regency Centers holdings fell to zero. The filing also updates prior indirect and direct ownership balances across several entities and corrects an earlier omission of 44,547 shares due to administrative error.
Regency Centers Corp Executive Chairman Martin E. Stein Jr. reported indirect transactions in the company’s common stock. On March 10 and March 11, the Joan W. Newton 2019 Revocable Trust, after receiving shares from The Regency Group II partnership where he is a general partner, sold 129,490 and 38,000 shares in open-market trades at weighted average prices of $78.334 and $77.2139 per share, totaling 167,490 shares sold. Separately, an irrevocable trust associated with him acquired 6,460 shares as a grant or award. Following these transactions, he continues to hold a significant stake, including 272,133 shares held directly and additional indirect holdings of 24,201, 110,263, and 4,000 shares through various trusts and a family-controlled corporation.
HERMAN MICHAEL R reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp reported that Senior VP and General Counsel Michael R. Herman received a grant of 7,215 shares of restricted stock on March 4, 2026. The award was granted at a price of $0.00 per share as part of his equity compensation.
All 7,215 shares are held as direct ownership after the transaction. According to the terms, the restricted shares vest in four equal installments of 25% each year, beginning on March 4, 2027.
REGENCY CENTERS CORP Principal Accounting Officer Terah L. Devereaux received a grant of 3,173 restricted stock shares. The Form 4 reports this as an acquisition awarded on March 4, 2026 at a stated price of $0.00 per share.
The award vests over time, with 25% of the restricted stock scheduled to vest each year beginning on March 4, 2027. Following this grant, Devereaux is reported as directly owning 3,173 shares related to this award.
Regency Centers Corp Executive Chairman Martin E. Stein Jr. sold 10,000 shares of common stock in an open-market transaction at an average price of $76.3001 per share. The sale used a weighted average price, with individual trades executed between $76.10 and $76.42. After the sale, he directly holds 272,133 common shares, in addition to several indirect holdings through trusts, a family-controlled corporation, and general partnerships.
Regency Centers Corp officer Devereaux Terah L, the Principal Accounting Officer, reported several equity-related transactions on February 12, 2026. The filing shows the exercise or conversion of derivative awards into 3,506 shares of Common Stock, partly linked to restricted stock vesting and dividend equivalents.
The report also shows a tax-withholding disposition of 1,479 shares of Common Stock at $73.40 to cover obligations tied to these awards. After these transactions, Devereaux Terah L directly owned 19,230 shares of Common Stock and 8,051 shares of Restricted Stock.
Regency Centers Corporation Senior VP and General Counsel Michael R. Herman reported equity award activity on February 12, 2026. He acquired 7,459 shares of common stock through the vesting and conversion of restricted stock and related dividend equivalents.
To cover tax obligations, 2,807 common shares were disposed of at $73.40 per share, leaving him with 21,601 common shares held directly and 4,257 shares of restricted stock. The company notes that a prior report understated his restricted stock grant by 538 shares, now correctly reflected as of February 17, 2026.
STEIN MARTIN E JR reported multiple insider transaction types in a Form 4 filing for REG. The filing lists transactions totaling 36,566 shares at a weighted average price of $73.40 per share. Following the reported transactions, holdings were 10,081 shares.
Regency Centers Corp President and CEO Lisa Palmer reported equity award activity. On February 12, 2026, she acquired 82,877 shares of common stock through the vesting and conversion of performance shares, restricted stock, and related dividend equivalents. On the same date, she disposed of 32,625 shares at $73.40 per share to satisfy tax withholding obligations. After these transactions, she directly owned 157,942 shares of common stock.
Regency Centers Corporation officer Nicholas Andrew Wibbenmeyer exercised stock awards and had shares withheld to cover taxes. On 02/12/2026 he acquired 17,345 shares of common stock through the conversion of 15,402 restricted stock units and 1,943 dividend equivalents. In a related tax-withholding transaction, 9,418 shares of common stock were disposed of at $73.40 per share. After these transactions, he directly owned 40,995.55 shares of Regency Centers common stock.
ROTH ALAN TODD reported multiple insider transaction types in a Form 4 filing for REG. The filing lists transactions totaling 41,594 shares at a weighted average price of $73.40 per share. Following the reported transactions, holdings were 30,203 shares.
Regency Centers Corp EVP and CFO Michael J. Mas reported equity award activity involving company stock. On February 12, 2026, he acquired 26,196 shares of common stock through the vesting and conversion of restricted stock and performance-based awards, including dividend-equivalent shares. To cover tax obligations, 10,367 common shares were disposed of at $73.40 per share through share withholding. After these transactions, he directly owned 54,849 shares of common stock and 37,001 derivative securities tied to restricted stock awards.
Regency Centers Corp officer Alan Todd Roth, Eastern Regional President and COO, reported selling 8,000 shares of common stock on February 10, 2026. The weighted average sale price was $77.05 per share, with individual trades ranging from $77.01 to $77.12.
After this transaction, Roth directly beneficially owns 14,991 shares of Regency Centers common stock. The sale was executed in multiple market transactions, and detailed price breakdowns are available upon request to the company or the SEC staff.
Regency Centers Corporation executive Michael J. Mas, EVP and CFO, reported a sale of company stock. On February 10, 2026, he sold 15,000 shares of Common Stock of Regency Centers Corp. at a price of $76.8501 per share. After this transaction, he beneficially owned 39,020 shares directly.
Regency Centers Corp President and CEO Lisa Palmer reported two transactions in the company’s common stock. On February 10, 2026, she made a gift of 6,233 shares at $0 per share, then sold 26,000 shares at a weighted average price of $76.75, in multiple trades between $76.42 and $77.01. After these transactions, she directly held 107,690 shares of Regency Centers common stock.
Regency Centers director C. Ronald Blankenship received 481 shares of common stock on February 4, 2026, coded as an acquisition. A footnote explains this represents director fees paid in stock under Regency’s Omnibus Incentive Plan. Following this award, he directly owns 112,351 common shares.
Regency Centers director Peter Linneman reported a routine stock-based compensation transaction. On February 4, 2026, he acquired 357 shares of common stock coded as an "A" (award) transaction. These shares represent director’s fees paid in stock under Regency’s Omnibus Incentive Plan. Following this award, he beneficially owns 53,600 shares of Regency Centers common stock held directly.
Regency Centers Corp director Karin Klein reported a stock-based compensation grant. On February 4, 2026, she acquired 428 shares of Regency Centers common stock, reported at a price of $0.00 per share, as director fees paid in stock under Regency's Omnibus Incentive Plan.
Following this grant, Klein beneficially owns 23,198 shares of Regency Centers common stock in direct ownership form. The filing reflects a routine equity compensation award rather than an open-market purchase or sale.
Regency Centers Corporation executive Nicholas Andrew Wibbenmeyer, West Regional President & CIO, reported an equity grant on a Form 4. He received 4,414 shares of restricted stock on February 3, 2026 at a stated price of $0 per share.
The filing shows he now beneficially owns 4,414 derivative securities, held directly. According to the footnote, these restricted shares vest 25% per year beginning February 3, 2027, meaning the award becomes earned gradually over four years.
Regency Centers Corp. executive Alan Todd Roth, Eastern Regional President and Chief Operating Officer, reported an equity award in the form of a restricted stock grant. On February 3, 2026, he received 4,414 restricted shares of common stock at a price of $0 per share, held directly.
The award is subject to a time-based vesting schedule. According to the footnote, the shares vest 25% per year beginning February 3, 2027, meaning the grant becomes fully vested over four years if the conditions are met.
Regency Centers Corp executive vice president and chief financial officer Michael J. Mas reported receiving a restricted stock grant of 5,601 derivative securities on February 3, 2026. These shares vest 25% annually beginning on February 3, 2027. Following this grant, he beneficially owns 5,601 shares directly.
Regency Centers Corp disclosed that Executive Chairman and director Martin E. Stein Jr. received a grant of 2,069 shares of restricted stock on February 3, 2026. The award was granted at a price of $0 per share and is held directly.
The restricted shares are scheduled to vest in four equal installments of 25% per year, beginning on February 3, 2027. Following this grant, Stein beneficially owns 2,069 derivative securities linked to Regency Centers common stock.
Regency Centers Corp. reported a new equity award to its President and CEO, Lisa Palmer. On February 3, 2026, she received a restricted stock grant covering derivative securities tied to 17,934 shares of common stock at a price of $0 per share.
The filing notes these shares vest in stages, with 25% of the award vesting each year beginning on February 3, 2027. The grant is held directly by Palmer and represents stock-based compensation that increases her beneficial ownership as the shares vest over time.
Regency Centers Corp (REG) insider reported an open-market sale. The Reporting Person, who is a Director and Executive Chairman, sold 15,000 shares of common stock at a weighted average price of $70.02 on 11/10/2025, with individual trades executed between $70.00 and $70.10.
After the transaction, the Reporting Person beneficially owned 272,958 shares directly. Indirect holdings were listed as 24,201 shares by a trust, 110,263 shares by a corporation, 325,382 shares by two general partnerships, and 4,000 shares by a trust for the Reporting Person’s benefit.